National Institute for Health and Care Excellence: Medical Treatments

(asked on 28th August 2020) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, when NICE plans to publish a timetable for technology appraisals delayed as a result of the covid-19 outbreak; and whether NICE plans to prioritise the appraisals of advanced therapy medicinal products.


Answered by
Helen Whately Portrait
Helen Whately
Minister of State (Department of Health and Social Care)
This question was answered on 14th September 2020

In response to the COVID-19 pandemic, the National Institute for Health and Care Excellence (NICE) paused the publication of topics that were not COVID-19 related or therapeutically critical to avoid distracting the National Health Service at a time of unprecedented pressure.

NICE has been working to reschedule multiple appraisals back into its work programme, to recover as quickly as feasibly possible. Information regarding the current timeline for each appraisal topic is published on the individual topic webpage on the NICE website.

NICE is committed to publishing final guidance for new products, including advanced therapy medicinal products within 90 days of the product first being licensed within the United Kingdom.

Reticulating Splines